Clinical Trials Browser

Completed × Interventional × yeast-CEA vaccine × Clear all

NCT01856920 2024-07-09

QUILT-3.006 for Recurrent Medullary Thyroid Cancer

Phase 2 Completed

35 enrolled 9 charts

Carcinoma, Medullary

NCT00924092 2019-12-12

An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...

Phase 1 Completed

BreastGastrointestinalGenitourinaryHead & NeckThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms